Researchers at the Clínic-IDIBAPS coordinated a study published in Blood Cancer Journal in which a new 3D system was developed from patient samples t1
The project led by Patricia Pérez Galán, the head of IDIBAPS’ Microenvironment in lymphoma pathogenesis and therapy research group, is the continuati1
The model was created by injecting tumour cells from a patient into a mouse. This makes it possible to imitate the leukaemia’s transformation into a1
There are still many questions surrounding lymphoma, its differences with leukemia and, above all, its treatment.
A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinica1
On Friday, 26 November, the dissemination seminar "Immunotherapy 2.0 in lymphoma: how to design personalized therapies" for patients and relatives wa1
The Hospital Clínic-IDIBAPS researcher has been awarded in the basic research category.
On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organization1
Researchers from IDIBAPS and CIBERONC have analysed the interaction between follicular lymphoma and its tumour microenvironment and propose a new pro1
Researchers from IDIBAPS-Hospital Clínic and CNAG-CRG in Barcelona have led a study to draw the first 3D maps of the genome of healthy and cancerous1
